Be Armed and Ready – the Asymmetrical Battlefield Could Be Here at Home
Supreme Leader Ayatollah Ali Khamenei's Death Wasn't the Only Satisfying Kill to Be...
CBS News Reporter Went Nuts Over This Photo of Susie Wiles in the...
Women’s Sports Just Aren’t As Entertaining As Men’s Are
Pete Hegseth, Vindicated (Part Deux)
Punctuated Living
The New American Century
The Law
The Left Is Petrified That Trump Will Succeed in Iran and Expose Them...
'Hanoi' Jane Typifies Hollywood Idiocy
FDA Cruelly Holding Up Approval of Treatments for Rare Diseases, Despite Children Likely...
10 Reported Dead After Pakistanis Attempt to Storm U.S. Embassy
Trump Calls on Iranian Military to Lay Down Arms or Face Certain Death
Thomas Massie Joins in With Democrat Allies Who Claim That Iran Strikes Are...
Miami Man Gets 4.5 Years in Prison for Possessing 450 Stolen or Counterfeit...
Tipsheet

Doctors Blast FDA Rush to Approve Fourth COVID Vaccine Dose

Doctors Blast FDA Rush to Approve Fourth COVID Vaccine Dose
(AP Photo/Rogelio V. Solis)

The Food and Drug Administration is expected to approve a fourth dose of Pfizer and Moderna's Wuhan coronavirus vaccine this week, despite a lack of clinical data showing they are effective or necessary.

Advertisement

"Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults," CBS News reported late last week. "The request is broader than rival pharmaceutical company Pfizer's request earlier this week for the regulator to approve a booster shot for all seniors."

Doctors truly focused on following the science, not political science, are blasting the decision.  

"The FDA’s vaccine regulation is sliding further into the abyss. Last week, Pfizer announced that it would seek emergency-use authorization for a fourth dose of its mRNA vaccine, based on the original Wuhan strain of Covid-19, in people over 65. Meantime, Moderna announced that it was seeking an even larger market share: a fourth dose in anyone over 18, based on its original mRNA vaccine. If the FDA moves forward on authorizing either product, it will cement a dangerous precedent: inadequate evidence being used to justify widespread vaccination for years to come," Dr. Vinay Prasad writes for City Journal. "The data supporting fourth doses aren’t up to medicine’s gold standard: a randomized trial. Instead, we have two observational studies comparing people who rushed to be boosted with those who didn’t."

Advertisement

Related:

MANDATE

As noted, a number of longtime FDA officials resigned last fall due to the approval process being rushed and concerns about side effects -- specifically enlargement of the heart in young people -- being ignored. Not to mention the CDC is just now getting around to studying side effects for women who have experienced serious changes in their menstruation cycles. 

Advertisement

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos